Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004460895 | SCV004958019 | uncertain significance | not specified | 2024-02-05 | criteria provided, single submitter | clinical testing | The c.5660G>A (p.C1887Y) alteration is located in exon 35 (coding exon 35) of the SSPO gene. This alteration results from a G to A substitution at nucleotide position 5660, causing the cysteine (C) at amino acid position 1887 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |